HCA Healthcare clears 200-day moving average on earnings beat
Alpha Vantage · MarketBeat · · AI-summarised by FinFlash
HCA Healthcare shares crossed above their 200-day moving average, reaching $434.46, with a consensus "Moderate Buy" rating and an average analyst target of $463.70. The company reported Q1 2026 revenue of $20.23 billion, up 8.7% year over year, and earnings of $7.59 per share, beating estimates. Risks include a Pomerantz investigation and an ongoing contract dispute with Cigna in Houston.
Understand the context
Published information may change. Summaries can contain errors; check the original source. Educational information only, not investment advice.